Skip to content

Clinical trials

Enrolling by invitation Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Enrolling by invitation Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
A2 Biotherapeutics Inc.1
Fujian Medical University Union Hospital1
Guangzhou Ruixin Biotechnological Co., LTD1
LI FENG1
Second Affiliated Hospital of Nanchang University1
University of Cologne1
Zealand University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma7
Carcinoma, Non-Small-Cell Lung2
Cachexia1
Carcinoma, Renal Cell1
Colorectal Neoplasms1
Head and Neck Neoplasms1
Kidney Neoplasms1
Lung Neoplasms1
Mesothelioma1
Ovarian Neoplasms1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.